info

product name:

Tenofovir Alafenamide Fumarate

cas No. :

1392275-56-7

MF :

2(C21H29N6O5P).C4H4O4

MW :

1069.02

Taian, China

9/F,E-commerce Industrial Park

+86 156 6659 0861

Mon to Fri 8am to 6 pm

greenindustry@163.com

Send us your inquiry anytime!

Detail

Tenofovir Alafenamide Fumarate  Quick Details

 

Product name:Tenofovir Alafenamide Fumarate

Synonyms:N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester (2E)-2-butenedioate (2:1);GS 7340-03

CAS No.:1392275-56-7

MF:2(C21H29N6O5P).C4H4O4

MW:1069.02

Molecular structure:

Appearance:White to off-white powder

Assay:≥99%

 

Tenofovir Alafenamide Fumarate  Properties

Item

Specifications

Results

Appearance

White to off-white powder

White powder

Assay

≥99%

99.2%

Any single impurity

≤0.1%

0.02%

Moisture

≤1%

0.6%

Heavy metals

≤20ppm

12ppm

Conclusion

The results conforms with enterprise standards

 

Tenofovir Alafenamide Fumarate  Usage

Tenofovir alafenamide (TAF), a novel nucleotide reverse transcriptase inhibitor developed by Gilead, treats chronic hepatitis B virus infection and compensatory liver disease. Tenofovir alafluamine is an oral prodrug of tenofovir (TFV), a modified version of the marketed drug tenofovirdisoproxil fumarate (TDF), compared to TDF, TAF clinically The dosage is smaller, and it is easier to enter the cell to exert the effect, the antiviral effect is stronger, and the adverse reaction is reduced.

Tenofovir Alafenamide Fumarate  Packaging

25kg/drum

Tenofovir Alafenamide Fumarate  Delivery

within 5~7 days

Tenofovir Alafenamide Fumarate  Storage

Store in a dry, well-ventilated place away from direct sunlight.

COA , TDS ,